Advertisement

The Scientist

» science funding

Most Recent

image: Money for Team Research

Money for Team Research

By | May 9, 2012

The University of Michigan is funding exploratory ideas that cross disciplinary boundaries with $20,000 a pop.

2 Comments

image: Congress Supports NIH Budget Increase

Congress Supports NIH Budget Increase

By | April 23, 2012

Petitions asking for more funding for the federal research agency are gaining bipartisan support in both the House and Senate.

2 Comments

image: $44 Million Earmarked for Research

$44 Million Earmarked for Research

By | April 19, 2012

Congress sets aside a large pot of pork-barrel funds for research projects in 2012, but not nearly as much as seen in pre-recession years.

2 Comments

image: The Best of Both Worlds

The Best of Both Worlds

By | April 1, 2012

Choosing to work in industry does not preclude a return to academe. But the move back takes some planning and finesse.

3 Comments

image: More Scrutiny for Senior Scientists?

More Scrutiny for Senior Scientists?

By | March 30, 2012

The NIH plans an extra layer of review for scientists with at least $1.5 million in existing grants.

2 Comments

image: MIT Students Petition Congress

MIT Students Petition Congress

By | March 27, 2012

Graduate students ask for more federal research support.

2 Comments

image: Pharma Puts Up Money for Biotech

Pharma Puts Up Money for Biotech

By | March 21, 2012

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.

0 Comments

image: Slipping from the Top?

Slipping from the Top?

By | March 14, 2012

Experts and the American public worry that the country is at risk of losing its global leadership position in scientific research.

24 Comments

image: Opinion: A Big Pharma Biotech Fund

Opinion: A Big Pharma Biotech Fund

By | March 5, 2012

Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.

4 Comments

image: Braving the IPO Drought

Braving the IPO Drought

By | March 1, 2012

Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.

0 Comments

Advertisement

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. A Case of Sexual Ambiguity, 1865
    Foundations A Case of Sexual Ambiguity, 1865

    This year marks the 150th anniversary of an autopsy report describing the first known case of a sexual development disorder.

  3. Influential Cancer Biologist Dies
  4. Image of the Day: Colorful Corn
Advertisement
Advertisement
Life Technologies